ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response
Richard D. Lutze, Matthew A. Ingersoll, Alena Thotam, Anjali Joseph, Joshua Fernandes, Tal Teitz
This study tests tizaterkib, an ERK1/2 inhibitor, for treating noise-induced hearing loss in mice, finding it protects hearing and reduces immune response.
International Journal of Molecular Sciences · Jun 7, 2024Peer-reviewedNeuroscience